Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations: results of the SAL MIDOKIT trial

Affiliations

• ¹ Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden. [email protected].
• ² Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden.
• ³ Institute of Pathology, University Hospital Dresden, Dresden.
• ⁴ Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany and German Cancer Research Center (DKFZ), Heidelberg.
• ⁵ Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt.
• ⁶ Department of Internal Medicine V, Nuremberg Hospital North, Paracelsus Medical University, Nuremberg.
• ⁷ Department of Internal Medicine V, University Hospital Erlangen, Erlangen.
• ⁸ Department of Internal Medicine III, Chemnitz Hospital, Chemnitz.
• ⁹ Department of Internal Medicine III, Hematology and Internal Oncology, University Hospital Regensburg, Regensburg.
• ¹⁰ Department of Internal Medicine II, Hematology and Internal Oncology, University Hospital Jena, Jena.
• ¹¹ Department of Internal Medicine, Hematology, Oncology and Immunology, University Hospital Marburg, Marburg.
• ¹² Department of Internal Medicine A, University Hospital Münster, Münster.
• ¹³ Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany; DKMS Clinical Trials Unit, Dresden.
• ¹⁴ Department of Internal Medicine I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig.
• ¹⁵ Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel.
• ¹⁶ Department of Internal Medicine V, University of Heidelberg, Heidelberg.
• ¹⁷ Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany; German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT) Dresden, Dresden.
• ¹⁸ Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany; Agendix GmbH, Dresden.